ubmslateAR-logo-ubm

AR Mobile Menu

Topics:

The AIDS Reader: AIDS and HIV News and Information

Vitamin D + Calcium ↓ Bone Loss from ART

Daily high-dose vitamin D and calcium supplements can reduce antiretroviral therapy-related bone loss by 50%.


©Tewan Banditrukkanka/shutterstock.com

Recent Content

©The Len/shutterstock.com

Clinically significant drug interactions involving antiretroviral agents have been reported in 30% to 40% of HIV-positive patients in the USA. However, this study finds that just a few therapeutic groups are responsible for most of the interactions detected.

©Tewan Banditrukkanka/shutterstock.com

Vitamin D and calcium supplementation is a low-cost, well-tolerated intervention to prevent ART-related bone loss, according to a new study.

©xrender/shutterstock.com

Here's compelling evidence that a screening program in primary care leads to an increased rate of HIV diagnosis.

 ©melis/shutterstock.com

Previous studies have established that early treatment of HIV dramatically reduces the odds of spreading the infection to a sexual partner. The START trial provides evidence that early therapy benefits a patient's own health.

Interest in preexposure prophylaxis is high among a diverse population of men who have sex with men who are at risk for HIV infection.

  ©Evdokimov Maxim/Shutterstock.com

A large increase in HIV and HCV infections in Indiana among injection drug users has prompted the CDC to issue a nationwide public health alert. Here's what you can do.

Rates of postoperative mortality among HIV-infected individuals who are receiving ART are low and influenced as much by hypoalbuminemia and age as by CD4 cell status, according to a new study.

By clicking Accept, you agree to become a member of the UBM Medica Community.